Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

Lung Cancer Treatments and Mutations

Работ: 26

  1. PD-L1 and p53 expression in squamous cell carcinoma of the oropharynx depending on human papilloma virus status

    D. Polatova, А. Yu. Madaminov, А. V. Savkin +5

    СтатьяHead and Neck Cancer StudiesHead and neck tumors (HNT)2023Цитирований: 2
    ABI

  2. Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer

    Sunil Kumar, Sounok Sengupta, Iqra Ali +4

    СтатьяQuinazolinone synthesis and applicationsJournal of Biomolecular Structure and Dynamics2023Цитирований: 1
    ABI

  3. Prognostic value of postoperative circulating tumor DNA for recurrence-free survival in resected non-small cell lung cancer: a systematic review and meta-analysis

    Atta Ullah Khan, Intizor Avazmetova, Mukhayya Ruzieva +4

    СтатьяCancer Genomics and DiagnosticsClinical & Translational Oncology2025Цитирований: 1
    ABI

  4. 16 QAM trial

    M. Cronin, B. Scott

    СтатьяLung Cancer Treatments and Mutations2005Цитирований: 0
    ABI

  5. Fostamatinib boosts QOL in RA

    СтатьяChronic Myeloid Leukemia TreatmentsPharmacoEconomics & Outcomes News2011Цитирований: 0
    ABI

  6. Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

    Andrea Riccardo Filippi, Angela Botticella, Marilena Bellò +9

    СтатьяLymphoma Diagnosis and TreatmentLeukemia & lymphoma/Leukemia and lymphoma2012Цитирований: 0
    ABI

  7. 130 Results of the Primary Treatment of Patients With Serous Ovarian Cancer Stage 2 in Relation to Degree of Process Differentiation

    M. Dilfuza

    СтатьяOvarian cancer diagnosis and treatmentEuropean Journal of Cancer2012Цитирований: 0
    ABI

  8. Kanzonol-Z

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    ГлаваMelanoma and MAPK Pathways2012Цитирований: 0
    ABI

  9. 27P The impact of hypolipidemic drugs on course and prognosis of lung cancer

    A.S. Almanova

    СтатьяCancer, Lipids, and MetabolismJournal of Thoracic Oncology2016Цитирований: 0
    ABI

  10. LungCARD - Report on worldwide research and clinical practices related to lung cancer

    Jankovic Radmila, Goncalves J Helena, Čavić Milena +6

    СтатьяLung Cancer Treatments and MutationsZenodo (CERN European Organization for Nuclear Research)2019Цитирований: 0
    ABI

  11. The Value of Multiple Drug Resistance in Colorectal Cancer

    Hurshid Islamov, Navruzov Sn

    СтатьяCancer, Lipids, and MetabolismEuropean Journal of Surgical Oncology2020Цитирований: 0
    ABI

  12. Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE)

    Lukáš Lambert, Lenka Janouskova, Matěj Novák +5

    СтатьяLung Cancer Diagnosis and TreatmentMedicine2021Цитирований: 0
    ABI

  13. Targeted Hot Spot Sequencing of Uzbek Lung Cancer Patients

    Zebinisa Mirakbarova, Turdikulova S. H

    СтатьяLung Cancer Treatments and MutationsBiomedical & Pharmacology Journal2021Цитирований: 0
    ABI

  14. Study of the effectiveness of chemotherapy in patients with colorectal cancer depending on the location of the metastatic lesion.

    Sergey Viktorovich Kamishov, Shakhnoza Niyozova

    СтатьяColorectal Cancer Treatments and StudiesJournal of Clinical Oncology2022Цитирований: 0
    ABI

  15. THE IMPORTANCE OF MARKERS CK7 AND TTF-1 IN METASTATIC LUNG TUMORS

    Khamidova Farida Muinovna, BOTIROV FURKAT TASHMUHAMADOVICH, NORTOJIEV JAHONGIR MUHAMMAD OGLI +1

    СтатьяCancer, Lipids, and MetabolismZenodo (CERN European Organization for Nuclear Research)2023Цитирований: 0
    ABI

  16. Combination of Carbonic Anhydrase Isoform IX Inhibitors and Gefitinib Suppresses on the Invasive Potential of Non-Small Cell Lung Cancer Cells

    Alexander S. Bunev, Антон А. Шетнев, Olga S. Shemchuk +9

    СтатьяEnzyme function and inhibitionBiochemistry (Moscow)2024Цитирований: 0
    ABI

  17. Effectiveness and safety of combined therapy with pemetrexed and bevacizumab in recurrent and metastatic cervical cancer.

    Shakhnoza Niyozova, Kamila Izrailbekova, Sergey Kamishov +3

    СтатьяEndometrial and Cervical Cancer TreatmentsJournal of Clinical Oncology2025Цитирований: 0
    ABI

  18. Exploring the GDP binding to KRas WT, G12C, G12D, G12R, and G12V and bound with MRTX1133 using steered molecular dynamics

    Abdulaziz Alamri, Showkat Ahmad Mir, Md. Shahnawaz Khan +3

    СтатьяMicrotubule and mitosis dynamicsEuropean Biophysics Journal2026Цитирований: 0
    ABI

  19. Knowledge, Attitudes, and Screening Practices for Lung Cancer in Uzbekistan: A Nationwide Cross-Sectional Study

    Asadbek Dadaboev, Malikakhon Shukurova, Azizkhon Aziziy +2

    СтатьяGlobal Cancer Incidence and ScreeningAsian Pacific Journal of Cancer Prevention2026Цитирований: 0
    ABI

  20. 1628 The First Comprehensive Genomic Landscape of Non-Small Cell Lung Carcinoma from Uzbekistan Reveals High TP53 Co-Mutations and Actionable Alterations in a 200-Patient Cohort

    Madina Jakhongirova, Mirzabek Shodmonov Isokul Ugli, Natalya Pak +4

    СтатьяLung Cancer Treatments and MutationsLaboratory Investigation2026Цитирований: 0
    ABI

  21. Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis

    Almuradova D.M., Ravshanova . N.B, Abdurakhimov A.I.

    СтатьяLung Cancer Treatments and MutationsInternational Journal of Medical Sciences And Clinical Research2026Цитирований: 0
    ABI

  22. Method Development And Validation For Estimation Of Related Substances In Selpercatinib Bulk Dosage Form By Rp-Hplc Technique

    Mr. Suraj P. Rajurkar, Mr. Salman Ahmad Khan, Mr. Shivprasad Sanjay Dhage +5

    СтатьяChronic Myeloid Leukemia TreatmentsInternational Journal of Drug Delivery Technology2026Цитирований: 0
    ABI

  23. Pre-analytical standardization and multi-biofluid harmonization for liquid biopsy biomarkers in lung cancer: From discovery to clinical laboratory implementation

    Shukhrat Sharapov, Mansur Tolibov, Фарида Муиновна Хамидова +6

    СтатьяLung Cancer Treatments and MutationsClinica Chimica Acta2026Цитирований: 0
    ABI

  24. PHARMACOLOGICAL PROPERTIES OF TYROSINE KINASE INHIBITORS: CURRENT PERSPECTIVES

    Kamola Anvarjon kizi Almirzayeva

    СтатьяChronic Myeloid Leukemia TreatmentsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  25. PHARMACOLOGICAL PROPERTIES OF TYROSINE KINASE INHIBITORS: CURRENT PERSPECTIVES

    Kamola Anvarjon kizi Almirzayeva

    СтатьяChronic Myeloid Leukemia TreatmentsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI